World News

Sevabertinib Shows Antitumour Activity in Patients with Locally Advanced or Metastatic...

Ogkologos - 14 Νοεμβρίου, 2025

FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma

Ogkologos - 13 Νοεμβρίου, 2025

EMA Recommends Extending Indications for Lisocabtagene Maraleucel

Ogkologos - 12 Νοεμβρίου, 2025

ESMO Launches First Congress on Artificial Intelligence and Digital Oncology: A...

Ogkologos - 12 Νοεμβρίου, 2025

Presence of Tumour and Higher Levels of LAG3-positive T-cells in the...

Ogkologos - 11 Νοεμβρίου, 2025

ESMO Calls for Cancer Care Safeguards in the EU’s Health Crisis...

Ogkologos - 11 Νοεμβρίου, 2025

PROs Support Switching to Camizestrant Plus CDK4/6 Inhibitor for HR-positive, HER2-negative...

Ogkologos - 10 Νοεμβρίου, 2025

Rucaparib Monotherapy Provides Significant and Durable Long-Term Benefit as First-Line Maintenance...

Ogkologos - 7 Νοεμβρίου, 2025

FDA Approves Belantamab Mafodotin-blmf for Relapsed or Refractory Multiple Myeloma

Ogkologos - 6 Νοεμβρίου, 2025

Long-Term Follow-Up Data Support Longer RFS with Adjuvant Nivolumab Than with...

Ogkologos - 5 Νοεμβρίου, 2025

1...333435...432 Σελίδα 34 από 432

MOST POPULAR

Trastuzumab Deruxtecan Leads to Longer PFS and OS Compared with Chemotherapy...

14 Ιουλίου, 2022

EMA Recommends Granting a Marketing Authorisation for Nirogacestat

3 Ιουλίου, 2025

Giving Birth Before Age 20 Cuts Breast Risk By 50%, And...

12 Δεκεμβρίου, 2019

Woman Battles Breast Cancer While Pregnant, Delivers Healthy Baby Boy

27 Οκτωβρίου, 2020

Φόρτωση περισσοτέρων

Sevabertinib Shows Antitumour Activity in Patients with Locally Advanced or Metastatic...

FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma

EMA Recommends Extending Indications for Lisocabtagene Maraleucel

ESMO Launches First Congress on Artificial Intelligence and Digital Oncology: A...

Presence of Tumour and Higher Levels of LAG3-positive T-cells in the...

ESMO Calls for Cancer Care Safeguards in the EU’s Health Crisis...

PROs Support Switching to Camizestrant Plus CDK4/6 Inhibitor for HR-positive, HER2-negative...

Rucaparib Monotherapy Provides Significant and Durable Long-Term Benefit as First-Line Maintenance...

FDA Approves Belantamab Mafodotin-blmf for Relapsed or Refractory Multiple Myeloma

Long-Term Follow-Up Data Support Longer RFS with Adjuvant Nivolumab Than with...

MOST POPULAR

Trastuzumab Deruxtecan Leads to Longer PFS and OS Compared with Chemotherapy...

EMA Recommends Granting a Marketing Authorisation for Nirogacestat

Giving Birth Before Age 20 Cuts Breast Risk By 50%, And...

Woman Battles Breast Cancer While Pregnant, Delivers Healthy Baby Boy

HOT NEWS

Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation...

EMA Recommends Extension of Therapeutic Indications for Osimertinib

New plan unveiled to tackle Scotland’s cancer crisis

Pan-FGFR Tyrosine Kinase Inhibitor Treatment Is Less Effective in Patients with...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ